- FTC Approves Final Order against The Bountiful Company in First Case Alleging Hijacking of Online Product Reviews ( )
- FTC to Host Public Workshop on Proposed Changes to Its Ophthalmic Practice Rules, also Known as the Eyeglass Rule, in May in Washington, DC ( )
- FTC Approves Final Order against LCA-Vision, Halting Alleged Bait-and-Switch Advertising for LASIK Laser Eye Surgery ( )
- FTC Sends Cease and Desist Letters to Prescribers Regarding Potential Violations of the Commission’s Contact Lens Rule ( )
- Statement of Elizabeth Wilkins, Director of the FTC’s Office of Policy Planning, on the Decision of SUNY Upstate Medical University and Crouse Health System, Inc. to Drop Their Proposed Merger ( )
- FTC Order to Bar ZyCal Bioceuticals from Deceptive Health Marketing ( )
- FTC Asks Federal Court to Hold ‘Pharma Bro’ Martin Shkreli in Contempt ( )
- FTC Order Requires LasikPlus to Pay for its Bait-and-Switch Eye Surgery Ads ( )
- FTC Proposes Updating Eyeglass Rule to Require Prescribers to Get Signed Confirmation When Providing a Prescription to Their Patients ( )
- FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition ( )
- FTC Staff Opposes Proposed Certificate of Public Advantage That Could Shield SUNY Upstate Medical University’s Acquisition of Crouse Health System from Antitrust Scrutiny ( )
- FTC Approves Final Order against JAB Consumer Partners to Protect Pet Owners from Private Equity Firm’s Rollup of Veterinary Services Clinics ( )
- New Mexico Physician Association to Pay $263,000 Civil Penalty to Settle FTC Allegations That it Violated 2005 Order ( )
- Administrative Law Judge Dismisses FTC’s Challenge of Illumina’s Proposed Acquisition of Cancer Detection Test Maker Grail ( )
- FTC Returning More Than $1.9 Million to Consumers Nationwide Who Purchased Hubble Contact Lenses Without Properly Obtained or Verified Prescriptions ( )
- FTC Policy Paper Warns About Pitfalls of COPA Agreements for Patient Care and Healthcare Workers ( )
- FTC Action Against Benefytt Results in $100 Million in Refunds for Consumers Tricked into Sham Health Plans and Charged Exorbitant Junk Fees ( )
- Una acción de la FTC contra Benefytt da como resultado $100 millones de dólares en concepto de reembolsos para los consumidores engañados con planes de salud falsos y a los que les cobraron cargos basura exorbitantes ( )
- FTC Approves Final Order Protecting Pet Owners from Private Equity Firm’s Anticompetitive Acquisition of Veterinary Services Clinics ( )
- FTC Approves Final Order Preserving Competition for Development and Marketing of Steroid Injectable Drug ( )
- FTC Approves Final Order Protecting Patients Who Rely on Medical Instruments Used in Sinus Procedures ( )
- Federal Trade Commission Returns More Than $5.4 Million to Consumers ( )
- FTC Takes Second Action Against JAB Consumer Partners to Protect Pet Owners from Private Equity Firm’s Rollup of Veterinary Services Clinics ( )
- FTC to Ramp Up Enforcement Against Any Illegal Rebate Schemes, Bribes to Prescription Drug Middleman That Block Cheaper Drugs ( )
- Statement of Bureau of Competition Director Holly Vedova Regarding the Decision of Utah Healthcare Competitors HCA Healthcare and Steward Health Care System to Abandon Their Proposed Merger ( )
- FTC Acts to Protect Pet Owners from Private Equity Firm’s Anticompetitive Acquisition of Veterinary Services Clinics ( )
- FTC and Justice Department to Hold Two-Day Virtual Public Workshop Starting Tomorrow that Re-examines Antitrust Enforcement in the Pharmaceutical Industry ( )
- FTC Launches Inquiry Into Prescription Drug Middlemen Industry ( )
- FTC Sues to Block Merger Between New Jersey Healthcare Rivals RWJBarnabas Health and Saint Peter’s Healthcare System ( )
- FTC Sues to Block Merger Between Utah Healthcare Rivals HCA Healthcare and Steward Health Care System ( )